Detalhe da pesquisa
1.
Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.
Lancet Infect Dis
; 22(5): 668-678, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065683